'Grey's Anatomy' exec: 'There could be more plane crash deaths'

Grey's Anatomy creator Shonda Rhimes has said that more characters could perish in the aftermath of last season's plane crash.

Lexie, played by Chyler Leigh, died of her injuries in the season eight finale earlier this month, which closed with Meredith (Ellen Pompeo), Derek (Patrick Dempsey), Cristina (Sandra Oh), Mark (Eric Dane) and Arizona (Jessica Capshaw) still stranded in the wilderness.

ABC / Richard Cartwright

Asked about the fate of the stranded Grey's characters, Rhimes told TV Guide: "Just because you saw people alive at the end of the finale doesn't mean they're going to be alive when the season starts up."

Rhimes previously confessed on Twitter that the finale, which also featured the departure of Teddy (Kim Raver) from Seattle Grace, had been "incredibly hard to write".

"I did not enjoy it," she claimed. "It made me sick and it made me sad.

"[Lexie's death] was a decision that Chyler and I came to together. We had a lot of thoughtful discussion about it and ultimately we both decided this was the right time for her character's journey to end."

Grey's Anatomy cast member Jesse Williams also acknowledged that it "was kind of depressing" to say goodbye to Leigh and Raver.

Read the original:
'Grey's Anatomy' exec: 'There could be more plane crash deaths'

Cognitive Code Announces "Silvia For Android" App

Pre-order the SILVIA for Android App on Kickstarter to experience conversational artificial intelligence on your Android phone.Sherman Oaks, CA (PRWEB) May 31, 2012 Cognitive Code Corporation, a company specializing in practical conversational artificial intelligence technologies, announces the SILVIA for Android personal assistant application. SILVIA for Android features practical integration ...

Read this article:

Cognitive Code Announces "Silvia For Android" App

AssureRx Health Raises $12.5 Million Series C Financing

MASON, Ohio, May 30, 2012 /PRNewswire/ --AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx ADHD, as well as next generation product development activities.

The financing was led by Four Rivers Group and existing investors Claremont Creek Ventures and Sequoia Capital. The financing also included participation of existing investors Cincinnati Children's Hospital Medical Center, Mayo Clinic, CincyTech, Allos Ventures, as well as new investors jVen Capital and Alafi Capital. New investors Four Rivers, jVen Capital, and Alafi Capital bring to AssureRx Health further expertise and partnering connections to help AssureRx Health continue building its leadership position in psychiatric pharmacogenomics.

"Our goal is to build the leading clinical informatics company providing pharmacogenomic and other treatment decision support products to help physicians individualize the treatment of patients with neuropsychiatric and other disorders," said James S. Burns, president and CEO of AssureRx Health. "Proceeds from the Series C financing will be used to expand sales coverage, sponsor multiple clinical studies, and develop new products to help accelerate our leadership position in psychiatric personalized medicine."

Warren Hogarth, partner at Sequoia Capital, said, "AssureRx products have the potential to change the way physicians select the appropriate medications for each of their patients. AssureRx is at the cutting edge of providing treatment decision support products for a very large global psychiatric market. We believe that AssureRx Health is building a world class company."

John Steuart, managing director of Claremont Creek Ventures said, "AssureRx has enormous potential to lead the transformation of neuropsychiatric care toward personalized patient treatment. GeneSightRx Psychotropic, GeneSightRx ADHD and future pharmacogenomic products hold the promise for faster, better patient outcomes and less costly care. We believe that AssureRx products have the potential for significant adoption by the psychiatric community, leading ultimately to incorporating pharmacogenomics into routine psychiatric practice guidelines."

From a simple cheek swab, the GeneSightRx technology measures and analyzes clinically important genetic variants that determine how a patient's unique genetic make-up affects his or her ability to tolerate or effectively respond to psychotropic medications. Patient-specific genetic information obtained through GeneSightRx can assist physicians in the process of selecting appropriate antidepressant and antipsychotic medications for individual patients.

About Claremont Creek Ventures Claremont Creek Ventures (CCV) is a seed and early stage venture firm. CCV invests in digital healthcare, energy technology, payments/commerce, and online businesses. Utilizing the firm's proprietary life-cycle venturing program, Claremont Creek Ventures also partners with entrepreneurs and institutions, including UC Berkeley, Lawrence Livermore Labs, Stanford University and UC Davis. Claremont Creek has more than $300 million in capital under management in two funds. CCV's digital healthcare investments in addition to AssureRx Health include Genalyte, GeneWeave, GigaGen, Fluxion Biosciences, Natera, Tibion and Zipline Medical. For more information, visit http://www.claremontcreek.com.

More:
AssureRx Health Raises $12.5 Million Series C Financing

Research and Markets: Europe Neurology Devices Market Outlook to 2018 – Interventional Neurology, Neurological …

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/dkz3lh/europe_neurology_d) has announced the addition of GlobalData's new report "Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Europe Neurology Devices market - France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include France, Germany, Italy, Spain and United Kingdom.

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Europe Neurology Devices market..

Continue reading here:
Research and Markets: Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

WAC Lighting Showcases Future of Solid State Lighting With Two New Organic LED Luminaires

GARDEN CITY, NY--(Marketwire -05/30/12)- Creating a symbiosis of eco-friendly nanotechnology and modern aesthetics that simply inspires, WAC Lighting continues to push boundaries with two new Organic LED luminaires that transform the future of lighting into a unique platform for today. WAC, a global manufacturing leader of decorative and architectural lighting, introduces the Vela Organic LED chandelier with a matching OLED wall sconce.

"Designed and engineered to stimulate curiosity and aesthetic appeal among the design and specification community, our next generation OLED luminaires raise the bar with a unique lighting experience of vision and sustainability," explained WAC Lighting President, Shelley Wald.

The Vela OLED Chandelier is defined by a dramatic contemporary profile laser-crafted of aluminum, with 12 OLED panels that illuminate surfaces below, and 12 additional OLEDs that shine upward to render a soft ambiance that evokes a lighter sense of space and visual comfort. The chandelier delivers a high light output of 2040 lumens while offering a CRI (color rendering index) of 80 and an efficacy of 35.2 lumens per watt. The luminaire features a total of 24 OLEDs with a CCT (correlated color temperature) of 4000K while using just 58 watts of power. Aircraft cables suspend the chandelier from the ceiling, with a height adjustment up to 36 inches.

"Our OLED luminaires are eco-friendly and sustainable," continued Ms. Wald. "They showcase a unique light source from an ultra-thin aesthetic design, integrated with the most advanced nanotechnology available today."

The Vela OLED wall sconce is designed in a unique decorative aluminum profile with six sophisticated OLED panels on its perimeter. Four square panels are connected in the center, by cross-shaped arms that are attached to two OLED panels on the ends. Housed within this exceptionally thin luminaire, the panels provide a wide, even illumination without glare. Perfect for use in hallways or as a decorative focal point, the brushed aluminum finished sconce uses 16.4 watts with OLED panels offering a 4000K CCT, a CRI of 80, and an efficacy of 31.1 lumens per watt while delivering 510 lumens. With a depth of merely 2.25 inches, the sconce is 24 5/8 inches long and 13 inches wide.

Inherently sustainable and precision engineered, the luminaires are individually crafted with the world's most revolutionary light source in WAC's wholly owned, zero landfill manufacturing campus. With instant on/off and dimming capabilities, the Vela family delivers mercury free, consistent beams of light without glare and a 10,000-hour rated life. The OLEDs are uniformly luminous and evenly spaced on the luminaires with utility, proportion and style.

Options include new materials and independently controlled micro-LEDs on a single circuit to enhance light intensity.

Documents and/or Photos available for this release:

OLED Wall WACOLED Chandelier

To view supporting documents and/or photos, go to http://www.enr-corp.com/pressroom and enter Release ID: 330646

Visit link:
WAC Lighting Showcases Future of Solid State Lighting With Two New Organic LED Luminaires

Edmonton Economic Development Corporation: Nanotechnology Institute Key to Regional Alliance

EDMONTON, ALBERTA--(Marketwire -05/30/12)- On the western edge of the University of Alberta's main campus lies the National Institute for Nanotechnology (NINT), one of the world's most advanced research facilities and Canada's quietest laboratory space.

One of the members of the Greater Edmonton Regional Technology Alliance, NINT's specialty is the world of individual atoms or molecules. The institute's research is about how to integrate nano-scale devices and materials (e.g. nano-coatings) into complex nanosystems connected to the outside world (e.g. heat or wear-resistant pipes or lab-on-chip devices similar to a blood glucose test for diabetics). For comparison, a strand of human hair measures up to 100,000 nanometres wide.

By enabling the nanotech community's collaboration and access to its facility and expertise, NINT helps Edmonton nanotechnology firms with commercialization and licensing.

Other Regional Alliance members include Edmonton Economic Development Corporation (EEDC), TEC Edmonton, novaNAIT, Northern Alberta Business Incubator, Business Link, TR Labs, the National Research Council's Industrial Research and Assistance Program, and Startup Edmonton.

"NINT is helping us all to better understand the emerging science of nanotechnology. As the only centre of its kind in Canada, it puts us in a leadership position. Being located at the University of Alberta creates great synergies," says Mike Wo, EEDC executive director of economic growth and development.

Mirroring the Regional Alliance, 12 private-sector companies have started a Greater Edmonton Nanotechnology Alliance to speak with a common voice for the emerging industry.

The Edmonton Research Park (ERP) houses dozens of research companies and is managed by Edmonton Economic Development Corporation (EEDC). The ERP is also a stakeholder in TEC Edmonton, a joint venture with the University of Alberta. For more information, visit http://www.edmonton.com Learn more about Edmonton through the stories of people who've experienced it at http://www.edmontonstories.ca

See the rest here:
Edmonton Economic Development Corporation: Nanotechnology Institute Key to Regional Alliance

Personality Secrets to a Long Life

Researchers Find Centenarians Optimistic, Extroverted, Positive; Some Became That Way Later in Life

May 30, 2012 -- A new study may offer some tips to help you stick around for your 100th birthday.

Try to be optimistic, easygoing, sociable, and conscientious. Don't bottle up your feelings. Suppress the urge to talk ill of others, the new research suggests.

That combination of personality factors seems to describe the secrets of living to 100, says researcher Nir Barzilai, PhD, director of the Institute for Aging Research at Albert Einstein College of Medicine in the Bronx, N.Y.

Those findings are among the latest from Barzilai's ongoing Longevity Genes Project.

While Barzilai found that those personality factors offer more clues to longevity, he has a caveat: "Still the No. 1 predictor for being a centenarian is if you have parents who are centenarians."

Even so, he is trying to answer the question: "Are the genes that are longevity genes also personality genes?"

The new research is published in the journal Aging.

Living to 100 years old is still rare. About 53,000 people in the U.S., or 0.2% of the population, are 100-plus. However, the number of centenarians has been increasing about 8% a year, Barzilai says.

And that has captured his research interest and that of others around the country. "There are several groups doing studies on centenarians," Barzilai says.

Original post:
Personality Secrets to a Long Life

Integrative Medicine: Antioxidants and chemotherapy

Inflammation, and the use of antioxidants to put out inflammatory fires, is a hot topic these days. What do we mean by inflammation?

Inflammation is a natural and necessary response in the body whenever we are accosted by harmful germs or when we injure ourselves. When this occurs, our immune system steps in to fight foreign invaders and to bring our body back into balance so that we can heal.

Inflammatory chemicals are produced during this process, which can be harmful to our tissues, but antioxidants in our foods, such as vitamins C and E, help to quell this response and restore order to our tissues.

Inflammation can run amok, however, and cause persistent damage to healthy tissue, especially if we smoke or if we are overweight or obese. Chemo- therapy drugs that are used to treat cancer also produce severe inflammation in the body, and this particular inflammatory response helps to kill off cancer cells. But it also harms healthy tissue in the process.

Many oncologists have been fearful of having their patients take any antioxidants during chemotherapy for fear that antioxidants might reduce the effectiveness of the chemo.

In a recent article in the journal Alternative and Complementary Therapies, Dr. Keith Block, a renowned integrative cancer specialist affiliated with the University of Illinois, discussed his review of more than 2,300 studies on the use of antioxidants during chemotherapy, and his report is very reassuring.

In summary, antioxidants often help to reduce side effects from chemotherapy, and this may allow patients to complete their full course of medication without interruption, which itself leads to better outcomes. Certain antioxidants also enhance the effectiveness of chemotherapy, reduce long-term toxicity and improve survival.

Not a single study reviewed by Block showed any evidence of antioxidants interfering with the effectiveness of chemotherapy. In fact, a recent article looking at the impact of antioxidants in Chinese women undergoing treatment for invasive breast cancer found that use of antioxidant vitamin supplements in the first six months after diagnosis resulted in a reduced risk of both mortality and cancer recurrence.

Other studies have suggested survival benefit in certain cancers when patients take melatonin, as well as reduced toxicity from chemo with the use of glutathione and coenzyme Q10 among others.

So if you are affected by cancer, what should you be thinking about to protect yourself during and after chemotherapy? First and foremost, begin by eating a super-healthful, plant-based diet that is loaded with dark-colored fruits and veggies so that you maximize your intake of antioxidants from your food, which is the most powerful way to get them.

More here:
Integrative Medicine: Antioxidants and chemotherapy

Milbank: Before GOP clones Reagan genetic flaws must be fixed

When news broke a vial of Ronald Reagans blood was being auctioned, the price quickly jumped to $30,000 as websites and blogs explored a tantalizing possibility: Did this mean the late president could be cloned?

Before mad scientists got the chance to perform a Dolly-the-Sheep experiment with the 40th president, the seller succumbed to criticism and decided to donate the blood to the Ronald Reagan Presidential Foundation. But this should only encourage the cloning speculation because the Gippers DNA is now in the hands of those who would most like to reproduce him: Republicans.

Party officials have been making the pilgrimage to the Reagan Library this year to express their wish to re-create the great man. I believe boldness and clarity of the kind that Ronald Reagan displayed in 1980 offer us the greatest opportunity to create a winning coalition in 2012, vice presidential aspirant Paul Ryan said at the library last week.

Also making the trip were VP hopefuls Marco Rubio and Chris Christie. Like Ronald Reagan, I believe in what this country and its citizens can accomplish, the latter declared. The America I speak of is the America Ronald Reagan challenged us to be.

The man they hope to join on the ticket, Mitt Romney, once boasted he was not trying to return to Reagan-Bush. Now he says the partys standard-bearer should be in the same mold as Ronald Reagan.

But before they go filling that mold by mapping the Reagan genome, Republicans may wish to consider some genetic flaws that party scientists should repair in the cloning process. To make the Reagan clone more compatible with todays Republican Party, a bit of genetic engineering may be in order:

AFL-1: Reagans AFL-1 gene, on the labor chromosome, has a mutation that made him susceptible to workers rights. He said of unions: There are few finer examples of participatory democracy. He said the right to join a union is one of the most elemental human rights. And he said collective bargaining played a major role in Americas economic miracle.

EPA-4: Reagans EPA-4 gene, on the regulatory chromosome, has a protein that can summon anti-industry sympathies. He signed a law establishing efficiency standards for electric appliances and an update to the Safe Drinking Water Act punishing states that didnt meet clean-water standards.

SSA-2 and MDCR-1: These related genes, on the long arm of the retirement chromosome, are problematic. Reagan expanded Social Security in 1983 and imposed taxes on wealthy recipients. He also signed what was at the time the largest expansion of Medicare in its history.

DEBT-1, DEBT-2, DEBT-3: A trio of abnormalities on the fiscal chromosome caused Reagan to increase taxes several times after his initial tax cut, to embrace much higher taxes on investments than current rates and to sign 18 increases in the federal debt limit.

Read the original here:
Milbank: Before GOP clones Reagan genetic flaws must be fixed

Chemistry 101: John Beilein says 5 new elements will help Michigan basketball team's cohesion

Attrition, as John Beilein puts it, is normal.

While statistics show that the Michigan basketball coach is probably right, there's nothing ordinary about having to replace five bodies inside every corner of your program.

Five new faces at practice, five new voices in the locker room, five new plates at the dinner table -- and five new personalities that need to be meshed together in an incredibly short amount of time for a program with extremely lofty immediate expectations.

Is Beilein worried?

Not really. He's the opposite, actually.

"My early sense for the younger guys coming in, I've watched some of them for three years, some for three months," Beilein told reporters earlier this month. "But I sense that they're all really good teammates, and they'll enhance team chemistry the minute they walk out here.

"Because they really have a great spirit about them."

Beilein expected to lose departed senior co-captains Zack Novak and Stu Douglass, the team's backbone, but didn't think he'd have to replace three other bodies.

That's exactly what happened, though, when Evan Smotrycz, Colton Christian and Carlton Brundidge left the program shortly after the season closed.

Michigan coach John Beilein believes his five incoming freshmen will enhance team chemistry because "they really have a great spirit about them."

Read more:
Chemistry 101: John Beilein says 5 new elements will help Michigan basketball team's cohesion

Global Markets for Media, Sera and Reagents in Biotechnology — Focus on Europe

NEW YORK, May 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Media, Sera and Reagents in Biotechnology -- Focus on Europe

http://www.reportlinker.com/p0870806/Global-Markets-for-Media-Sera-and-Reagents-in-Biotechnology----Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

INTRODUCTION

STUDY OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. The key objective is to present a comprehensive analysis of the current market and its future direction in the media, sera and biotechnology reagents markets as an important tool for the cell culture industry.

This report explores present and future strategies within the media and sera market, including reagents used in biotechnology. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The types of cell cultures and the products from cell culture technology are also presented in this report. The advantages and disadvantages for the use of various types of media are also covered in this report.

A detailed analysis of the cell culture industry structure has been conducted. This includes the biotechnology reagents, media and the sera used. Revenues are broken down by global region. Sales figures are estimated for the five-year period from 2011 through 2016.

Applications for the cell culture industrymedia, sera and reagents used in biotechnologyare also discussed in the report, with an emphasis on the usage in the research, production and contract segments. The report also covers significant patents in each segment.

REASONS FOR DOING THIS STUDY

Excerpt from:
Global Markets for Media, Sera and Reagents in Biotechnology -- Focus on Europe

Global Markets for Media, Sera and Reagents in Biotechnology

NEW YORK, May 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Media, Sera and Reagents in Biotechnology

http://www.reportlinker.com/p0870777/Global-Markets-for-Media-Sera-and-Reagents-in-Biotechnology.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

INTRODUCTION

STUDY OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. The key objective is to present a comprehensive analysis of the current market and its future direction in the media, sera and biotechnology reagents markets as an important tool for the cell culture industry.

This report explores present and future strategies within the media and sera market, including reagents used in biotechnology. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The types of cell cultures and the products from cell culture technology are also presented in this report. The advantages and disadvantages for the use of various types of media are also covered in this report.

A detailed analysis of the cell culture industry structure has been conducted. This includes the biotechnology reagents, media and the sera used. Revenues are broken down by global region. Sales figures are estimated for the five-year period from 2011 through 2016.

Applications for the cell culture industrymedia, sera and reagents used in biotechnologyare also discussed in the report, with an emphasis on the usage in the research, production and contract segments. The report also covers significant patents in each segment.

REASONS FOR DOING THIS STUDY

Follow this link:
Global Markets for Media, Sera and Reagents in Biotechnology

Anatomy of a Parade

esther rabinowitz

Zionist Bikers: Youth groups and day schools dominate the annual Israel parade in New York. But theres room for bikers, too.

New York Citys Celebrate Israel Parade is one of a kind. An annual Zionist promenade up Manhattans Fifth Avenue, the 47-year-old festival is a Jewish take on the classic New York City ethnic parade. Theres nothing else quite like it in the country. In fact, its probably the biggest annual celebration of Israel in the world, outside of the Jewish state itself.

But what is the parade, besides countless Israeli flags, glad-handing politicians and oceans of day school kids? The Forward has crunched the numbers. A picture emerges of an event that is largely Modern Orthodox, heavily suburban and mostly made up of groups of young people.

This years parade, organized by the Jewish Community Relations Council of New York, is scheduled for June 3. The day begins with a Celebrate Israel Run through Central Park at 8 a.m. The parade kicks off at 11 a.m. on Fifth Avenue and 57th Street, and will air on local television station WWOR channel 9.

Read more:
Anatomy of a Parade

Nutrition Enhancement Launches Halal Certified Gelatin-Free Multivitamin

St Louis, MO (PRWEB) May 31, 2012

Nutrition Enhancement Inc., a manufacturer and distributor of Halal Omega-3 fish oil, has announced the launch of halal certified gelatin-free multivitamin product. Nutrition Enhancement Multivitamin is specially formulated with key nutrients to support the health of both men and women of all ages. The product is equivalent to leading brands in the market, but it is formulated without gelatin. It is the only halal certified multivitamin with 1000 IU of Vitamin D3. The product is designed to support immunity, physical and mental energy, and the health of the heart, breast, prostate, colon, bone, eye, and skin.

Market data shows that people have vitamin deficiencies, especially in vitamin D. Emerging research shows that vitamin D is necessary for optimal health. Issues arise when individuals do not expose to sun (source of vitamin D), particularly Muslim women due to a dress code that involves wearing of the scarf or Hijab. With just a single tablet, this exciting product provides the key nutrients, including 1000 IU Vitamin D3.

Feedback from customers and physicians has been overwhelmingly positive and warmly welcomed. We look forward to the continued expansion of our product portfolio of high quality, safe, and innovative products that meet the needs of health conscious Muslims, said Emad Yasseen, Director of Scientific Affairs.

Nutrition Enhancement Multivitamin is gelatin free and halal certified by Islamic Services of America (ISA). It is challenging today for Muslims to find high quality dietary supplements that meet the Halal guideline. The majority of multivitamins supplements brand contain animal gelatin as shown on the label. Most of the animal gelatins are made from pork by-products. For this reason, many Muslims do not take dietary supplements despite the health benefits. Those that do, are most probably unaware of this, Emad further explained.

About Nutrition Enhancement: Nutrition Enhancement is committed to helping people live healthier lives through science, innovation, and quality. Nutrition Enhancement is an important part of the health and wellness market and dedicated to developing healthy supplements according to Islamic guidelines, in order to meet the needs of health conscious Muslim families. Nutrition Enhancement dietary supplements are manufactured in the USA in a GMP (Good Manufacturing Practice) facility in accordance with US Food and Drug Administration. For more information about Nutrition Enhancement's products, please visit http://www.nutritionenhancement.com Contact Information:

Emad Yasseen, Ph.D. Director of Scientific Affairs Nutrition Enhancement P.O. Box 1083 Ballwin, MO 63022-1083

Phone: 636-489-8717 http://www.facebook.com/NutritionEnhancement

Read the original here:
Nutrition Enhancement Launches Halal Certified Gelatin-Free Multivitamin

Honoring the fundamental role of microbes in the natural history of our planet

Public release date: 30-May-2012 [ | E-mail | Share ]

Contact: Courtenay S. Brown csbrown@asmusa.org 202-942-9316 American Society for Microbiology

Inspired by a 2009 colloquium on microbial evolution convened at the Galapagos Islands, a new book from ASM Press, Microbes and Evolution: The World That Darwin Never Saw celebrates Charles Darwin and his landmark publication On the Origin of Species. The editors compiled 40 first-person essays, written by microbiologists with a passion for evolutionary biology, to illuminate how each scientist's thinking and career paths in science were influenced by Darwin's seminal work.

Intended for a general audience, Microbes and Evolution explores how the evidence of microbial evolution deeply and personally affected each scientist. Readers can expect to be surprised and delighted with these intimate viewpoints on the importance of evolutionary principles in the study of a variety of aspects of life science, from taxonomy, speciation, adaptation, social structure, and symbiosis to antibiotic resistance, genetics, and genomics.

"Despite the political rhetoric about evolution, microbes provide compelling examples of natural selectionexamples that affect all of our lives every day. We thought the best way to tell these stories was to ask scientists who work in this field to share their discoveries in a way that explains why they find microbial evolution exciting and important. And along the way, they provide interesting insights into how they think about science, revealing personalities that are as diverse as the microbes they study," say Roberto Kolter of Harvard Medical School who co-edited the book with Stanley Maloy of San Diego State University.

"To celebrate the anniversary of both Darwin's birth and the publication of On the Origin of Species, a select group of microbiologists met in the Galapagos Islands, bent on reconciling modern microbiology with classical evolutionary theory. Their essays, born of this historic gathering, appear here, each written in an erudite yet highly personal style. Consequently, this book is not only highly informative, but a great deal of fun to read. About half of them had something to say about Darwin; the other half, what Darwin would have said about them," says Moselio Schaechter, distinguished professor emeritus, Tufts University School of Medicine; adjunct professor emeritus, Department of Biology, San Diego State University; and, visiting scholar, University of California at San Diego.

Richard Losick, Maria Moors Cabot Professor, at Harvard University, describes Microbes and Evolution as "A breathtaking range of topics are woven together under a common theme that takes the reader from the origin of microbial life to its diversity, from mutualism and competition to efforts to recapitulate evolution, from the diversity of bacterial viruses to 'the smallest and most abundant microorganism in the ocean.'"

"This book is an excellent collection of articles and should be read by everyone working with bacteria (and others as well) or thinking of doing so," says Charles Yanofsky, professor emeritus, Department of Biology, Stanford University.

###

Roberto Kolter did his academic training at Carnegie-Mellon University, UC San Diego, and Stanford. Since 1983 he has been a faculty member of Harvard Medical School. A fanatic of food and wine, he enjoys burning those calories off in early morning runs along the Charles River in Boston.

Read this article:
Honoring the fundamental role of microbes in the natural history of our planet

Skydiggers celebrate their longevity

Now approaching a quarter-century in existence, Skydiggers are a band that needs little introduction.

The groups 1989 self-titled debut and the still-devastating single A Penny More from their 1992 follow-up Restless long ago earned the bands roots-folk sound a deserved spot in the CanRock canon.

Northern Shore, released last month on the Latent Recordings label, is their eighth studio release and marks the beginning of a new chapter for the group. Its their first recording since 2009s The Truth About Us, a best-of retrospective that doubled as a 20th anniversary celebration of their career. As singer Andy Maize explained on the eve of setting out on the bands latest tour, combing the archives for The Truth About Us allowed the group, whose lineup includes fellow founding members Josh Finlayson (guitar) and Ron Macey (bass), a chance to consider their journey to date.

We went through a lot of old material choosing the songs for that retrospective and that just got us thinking about some of the things that we had done in the past and got us thinking about some of the older songs as well. So I think that part of the new recording was informed by the retrospective, he said.

The collection came about after several years of prodding by music industry executive Kim Cooke, who signed the group to Warner Music Canada in 1994 where they released their third record, Road Radio. Though Skydiggers fans may have initially feared the anthology was intended as a swan song, Maize said the groups future was never in doubt.

We thought that 20 years was worth celebrating and Kim had a big role in putting together the retrospective, but it was never meant to be a farewell or a parting shot. For us, it was rewarding because we got to reflect over what wed done and that definitely helped us to move forward, he said.

For Northern Shore, the band enlisted producer Saam Hashemi, who guided them through an unorthodox recording process that Maize said had the band putting songs to tape in whatever way made sense. That included working up tracks from simple guitar and vocal takes in Finlaysons basement to separate sessions at Blue Rodeos Woodshed recording space and live-off-the-floor recordings made at the Tragically Hips Bathouse studio near Kingston, Ont.

Saams abilities gave us the flexibility to record in different ways, Maize said.

The album is also available in a four-disc deluxe edition that will delight longtime fans, with highlights including the bands original 1988 demo (recorded at Grant Avenue studio in Hamilton) and mid-90s sessions recorded at Chemical Sound in Toronto that were the last to feature founding member Peter Cash until now.

Weve been doing more work with Peter recently, said Maize. We recorded some of his material for Northern Shore, he sings on some of the songs on Northern Shore, so it just seemed like a good way of reconnecting with some of that older material, which we still play live.

Go here to read the rest:
Skydiggers celebrate their longevity

Michael Franke, Coaching Longevity and a Stanley Cup Prediction on Puska on Pucks

by Denis Puska May 30, 2012 - ECHL (ECHL) Fort Wayne Komets A prediction and preview of the Stanley Cup Championship Series and an interview with the President of the Fort Wayne Komets who will call the ECHL home this fall highlights Episode 42 of Puska on Pucks, The Original Internet Hockey Show.

Join host Denis J. Puska as he spends time with Komets President Michael Franke to discuss the move from the Central Hockey League to the ECHL. Franke will also talk about the new rivalries the Komets will enjoy in the new league.

Coaching Longevity is something that isn't talked about that much anymore. But two coaches still believe that longevity with one team can still be found. Ft. Wayne Komets Head Coach Al Sims and Columbus Cottonmouths Head Coach and General Manager Jerome Bechard have combined for 26 years in the same city. Sims and Bechard will share their thoughts on the cities they have called home for an extended period of time.

The NHL's Stanley Cup final features the Los Angeles Kings and the New Jersey Devils. Puska will have a preview of the final series and his prediction of who will take home the Cup.

The Phoenix Coyotes have come off an outstanding season in the NHL, but there still is speculation regarding their future in Arizona. Puska on Pucks has some information regarding the Coyotes and the ownership situation there.

Ice Chips News and Notes Presented By TST Media has Central Hockey League Awards Results from their annual convention, and how one AHL team the Manchester Monarchs are Crossing Borders and trying to eliminate discrimination on and off the ice.

Listen to new and past episodes of the weekly pod-cast at http://www.puskamediaservices.com under the Puska on Pucks tab. Several other websites also carry the program including the Michigan Regional Sports Network, SPHL Forums and http://www.oursportscentral.com under the OSC Radio link section.

Discuss this story on the ECHL message board... Digg this story Add to Del.icio.us

The opinions expressed in this article are those of the writer(s), and do not necessarily reflect the thoughts or opinions of OurSports Central or its staff.

Go here to see the original:
Michael Franke, Coaching Longevity and a Stanley Cup Prediction on Puska on Pucks

Longevity the mark at school

VEEDERSBURG, Ind. Teachers retiring at Fountain Central High School have enjoyed their time with the students and staff.

Dan Halladay, Phil Rash and Dorie Johnson are leaving with more than 30 years at the school. And while Brad Smiths time at Fountain Central is much shorter, he has been in education for 40 years.

I wanted to teach since I was in elementary school, Halladay said. I liked grading, and I liked teaching other kids.

Halladay was involved in coaching, including 10 years with girls basketball, one year in baseball, three years in girls track, 10 years as a football assistant and 10 years with junior high football.

I have really enjoyed it, Halladay said. We have very good community support. We have tons of great people.

He will continue to work with a football officiating crew and umpire girls softball. He also sells sports cards on eBay.

Halladay is proud that four of his former students are now school superintendents.

Many others are pillars of their community, he said. I have lots of friendships from teachers and coaches.

Halladay estimated that 60 percent of his students now are second generation from local families.

Halladay took students to Russia in 1995 and has taken students to Germany four times, a program that continues annually at Fountain Central.

View post:
Longevity the mark at school